Kyung Dong Pharmaceutical Co. Ltd (011040) — Long-term Investment Intensity
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Long-term Investment Intensity of 17.5% as of December 2019. Long-term investments of ₩50.33 Billion represent 17.5% of total assets of ₩287.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 011040 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kyung Dong Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Kyung Dong Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 17.5%, reflecting long-term investments of ₩50.33 Billion against total assets of ₩287.59 Billion KRW. For the complete balance sheet picture, see 011040 current and non-current assets.
Annual Long-term Investment Intensity for Kyung Dong Pharmaceutical Co. Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Kyung Dong Pharmaceutical Co. Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 011040 liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 17.5% | ₩50.33 Billion | ₩287.59 Billion | ▲ +4.5 pp |
| 2018 | 13.0% | ₩33.50 Billion | ₩257.79 Billion | ▼ -3.0 pp |
| 2017 | 16.0% | ₩40.18 Billion | ₩251.43 Billion | ▲ +6.0 pp |
| 2016 | 10.0% | ₩23.89 Billion | ₩238.49 Billion | ▼ -8.4 pp |
| 2015 | 18.4% | ₩42.92 Billion | ₩233.41 Billion | ▲ +7.5 pp |
| 2014 | 10.9% | ₩24.76 Billion | ₩227.68 Billion | — |